Bharat Biotech Covid-19 vaccine

Covaxin can be taken off 'clinical trial mode', expert panel recommends
Coronavirus chronicle

Covaxin can be taken off 'clinical trial mode', expert panel recommends

In clinical trial mode, people needed to sign a consent form to take Covaxin, one of the two vaccines allowed for use in India, the other being Oxford-AstraZeneca's Covishield, developed by...

Covaxin shows interim clinical efficacy of 81% in Phase 3 results
Coronavirus chronicle

Covaxin shows interim clinical efficacy of 81% in Phase 3 results

Modi's ministers choose 'Made in India' vaccine over AstraZeneca
Coronavirus chronicle

Modi's ministers choose 'Made in India' vaccine over AstraZeneca

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

Brazil to buy 20 million Covid-19 vaccines from India's Bharat Biotech

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

Indian vaccine makers say can quickly adapt to tackle variants

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

Indian state rejects Bharat Biotech vaccine approved without efficacy data

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's Covid-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Coronavirus chronicle

India's COVAXIN likely effective against UK variant - study

Workers pack syringes at the Hindustan Syringes factory in Faridabad, India on Sept. 2, 2020. SAJJAD HUSSAIN/AFP/GETTY IMAGES
Analysis

India’s vaccine diplomacy

Representational image. Picture: Collected
Coronavirus chronicle

Bharat Biotech's Covid-19 shot safe, produced immune response in early human trial

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Covid-19 in Bangladesh

India's Bharat Biotech seeks Bangladesh trial for Covid vaccine approved at home

Representational image. Picture: Collected
Coronavirus chronicle

Covid-19 vaccines: Fact sheets in India warn against use in immuno-compromised